8-K/A: Hillenbrand Corrects Fiscal 2025 Outlook After Reporting Q2 Results

Sentiment:

Earnings Release


Hillenbrand updates its fiscal 2025 outlook due to tariffs and macroeconomic uncertainty after reporting a decrease in revenue and adjusted EPS for the second quarter.

Worse than expectedThe company's revenue and adjusted EPS decreased compared to the prior year.The company is updating its annual guidance range to reflect backlog levels exiting the fiscal second quarter and the impact of tariffs, including the indirect impact of further order delays due to increased macroeconomic uncertainty.

Summary

  • Hillenbrand reported its fiscal second quarter 2025 results, which ended March 31, 2025.
  • The company is correcting guidance for Molding Technology Solutions (MTS) revenue and year-over-year percentages, as well as adjusted EPS year-over-year percentages.
  • Net revenue decreased by 9% to $716 million compared to the prior year, primarily due to lower volume in the Advanced Process Solutions (APS) segment.
  • GAAP EPS decreased to $(0.58) from $0.09 in the prior year, mainly due to a loss on the sale of the majority stake in the Milacron injection molding and extrusion business.
  • Adjusted EPS decreased by 21% to $0.60 compared to the prior year, primarily due to lower APS volume.
  • The company completed the sale of a majority stake in the Milacron injection molding and extrusion business on March 31st, using the ~$265 million net proceeds for debt pay down.
  • Fiscal 2025 outlook is being updated to reflect the impact of tariffs and elevated macroeconomic uncertainty, with full-year EPS now expected to be $2.10 $2.45 and Q3 adjusted EPS of $0.46 to $0.53.
  • The company entered into a definitive agreement to sell the TerraSource business to Astec Industries for $245 million, expected to close in late fiscal third quarter or early fiscal fourth quarter 2025.

Sentiment

Score: 5

Explanation: The sentiment is neutral to slightly negative. While the company is taking actions to mitigate risks and focusing on long-term growth, the current results and updated guidance reflect challenges due to tariffs and macroeconomic uncertainty.

Positives

  • The sale of the Milacron stake generated ~$265 million in net proceeds, which were used to reduce debt.
  • The company is selling TerraSource for $245 million, expecting ~$100 million in after-tax cash proceeds, further reducing debt.
  • Solid year-over-year order growth was experienced in the food, health, and nutrition portfolio, as well as separation products.
  • Relatively stable performance in APS aftermarket and across MTS was experienced.

Negatives

  • Net revenue decreased by 9% year-over-year to $716 million.
  • GAAP EPS decreased significantly to $(0.58) from $0.09 year-over-year.
  • Adjusted EPS decreased by 21% to $0.60 year-over-year.
  • The company is updating its annual guidance range to reflect backlog levels exiting the fiscal second quarter and the impact of tariffs, including the indirect impact of further order delays due to increased macroeconomic uncertainty.

Risks

  • Global macroeconomic conditions have worsened, with increased uncertainty around tariffs.
  • Customers are expected to remain cautious in their capital investment decisions due to tariffs and heightened macro uncertainty.
  • The company faces risks related to environmental regulation and industry standards, as well as physical risks of climate change.
  • There is uncertainty in U.S. global trade policy and risks with governmental instability in certain parts of the world such as Germany.
  • The company faces adverse foreign currency fluctuations and labor disruptions.

Future Outlook

Hillenbrand is updating its fiscal 2025 guidance, expecting revenue between $2.555 billion and $2.620 billion and adjusted EPS between $2.10 and $2.45, reflecting the impact of tariffs and macroeconomic uncertainty.

Management Comments

  • Kim Ryan, President and Chief Executive Officer of Hillenbrand, stated that she was pleased with the business performance given the worsening global macroeconomic conditions.
  • Kim Ryan mentioned that the company expects customers to remain cautious in their capital investment decisions due to increased tariffs and heightened macro uncertainty.
  • Kim Ryan noted that the company is executing strategies to strengthen the supply chain and mitigate increased costs.
  • Kim Ryan expressed confidence in the long-term growth prospects of the company's end markets and the strong competitive positioning of its industry-leading brands.
  • Kim Ryan believes the portfolio transformation positions the company to drive profitable growth once macro conditions improve.

Industry Context

The announcement reflects the challenges faced by industrial companies due to global macroeconomic uncertainty and tariffs, impacting capital investment decisions and supply chains. Competitors in the industrial sector are likely facing similar headwinds, requiring strategic adjustments to navigate the evolving landscape.

Comparison to Industry Standards

  • Given the impact of tariffs and macroeconomic uncertainty, Hillenbrand's revised guidance aligns with the cautious outlook shared by other industrial companies such as Caterpillar and Deere & Company, which have also cited similar challenges in their recent earnings reports.
  • The divestiture of the Milacron injection molding and extrusion business mirrors the trend of companies focusing on core, higher-margin businesses, similar to actions taken by Siemens and ABB in recent years.
  • The sale of TerraSource to Astec Industries is in line with industry consolidation trends, as companies seek to strengthen their market position and expand their product offerings, similar to the merger of Metso and Outotec in the mining equipment sector.

Stakeholder Impact

  • Shareholders will be impacted by the decreased earnings and revised guidance.
  • Employees may be affected by the company's strategies to strengthen its supply chain and mitigate increased costs.
  • Customers may experience caution in their capital investment decisions due to tariffs and heightened macro uncertainty.
  • Suppliers may be affected by the company's efforts to strengthen its supply chain and mitigate increased costs.

Next Steps

  • The company expects to close the sale of the TerraSource business in late fiscal third quarter or early fiscal fourth quarter 2025.
  • The company will continue to execute strategies to strengthen its supply chain and mitigate increased costs.
  • Hillenbrand's financial statements on Form 10-Q are expected to be filed jointly with this release and will be made available on the company's website.

Key Dates

DateDescription
March 31, 2025End of fiscal second quarter 2025; Completion of the sale of majority stake in Milacron injection molding and extrusion business.
April 29, 2025Date of original Form 8-K filing and press release; Date of this amended Form 8-K/A filing; Date of definitive agreement to sell TerraSource business.
April 30, 2025Date of the conference call to discuss the results.
Late fiscal third quarter or early fiscal fourth quarter 2025Expected closing of the TerraSource transaction.
May 14, 2025Replay of conference call available until this date.
May 30, 2025Webcast archived through this date.

Keywords

Hillenbrand, earnings, fiscal 2025, Q2 results, guidance, MTS, APS, Milacron, TerraSource, tariffs, macroeconomic uncertainty

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.